WO1993001822A1 - Stable, anticorrosive peracetic/peroxide sterilant - Google Patents

Stable, anticorrosive peracetic/peroxide sterilant Download PDF

Info

Publication number
WO1993001822A1
WO1993001822A1 PCT/US1992/005877 US9205877W WO9301822A1 WO 1993001822 A1 WO1993001822 A1 WO 1993001822A1 US 9205877 W US9205877 W US 9205877W WO 9301822 A1 WO9301822 A1 WO 9301822A1
Authority
WO
WIPO (PCT)
Prior art keywords
concentrate
ppm
weight
added
hydrogen peroxide
Prior art date
Application number
PCT/US1992/005877
Other languages
French (fr)
Inventor
Louis C. Cosentino
Walter B. Jansen
Robert T. Ii Hall
Rosario M. Marino
Kimberly L. Hall
Original Assignee
Minntech Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minntech Corporation filed Critical Minntech Corporation
Priority to AU24100/92A priority Critical patent/AU661862B2/en
Priority to DE69231686T priority patent/DE69231686T2/en
Priority to US08/162,065 priority patent/US5508046A/en
Priority to BR9206266A priority patent/BR9206266A/en
Priority to JP5502905A priority patent/JP2523085B2/en
Priority to EP92916914A priority patent/EP0649310B1/en
Priority to AT92916914T priority patent/ATE199058T1/en
Priority to DK92916914T priority patent/DK0649310T3/en
Publication of WO1993001822A1 publication Critical patent/WO1993001822A1/en
Priority to GR20010400504T priority patent/GR3035654T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides

Definitions

  • This invention relates generally to the field of microbicides.
  • a stable microbicide having anticorrosive properties comprising a mixture of hydrogen peroxide, peracetic acid, acetic acid and purified water which is substantially free of contaminants or stabilizing and seguestrant type additives.
  • Peracetic acid/peroxide containing compositions have a long history of use as disinfectants and sterilizers due to their microbicidal activities. However, peroxide containing compositions are high-energy-state compounds and as such can be considered thermodynamically unstable.
  • Stabilizers may be agents such as sodium pyrophosphate, phosphonic acid or chelating agents such as 8-hydroxyquinoline. Stabilizers act by removing trace metals which accelerate the decomposition of peroxides. Stabilizers also accelerate the reaction between hydrogen peroxide and acetic acid to form peracetic acid. Therefore, for any given concentration of hydrogen proxide and acetic acid, the addition of a stabilizer increases the concentration at equilibrium of peracetic acid.
  • a use-dilution formulation that may be reused several times, is stable for relatively long periods in the diluted form and possesses anticorrosive properties would be a further advantage over conventional formulations.
  • Summary of the Invention It is an object of the stable, anticorrosive concentrate and use-dilution microbicides in accordance with the present invention to solve the problems outlined above that has heretofore inhibited long-term storage and the anticorrosive sterilization of surgical and dental instruments.
  • These improved microbicide solutions not only have the desired stability but have been shown to have a significantly reduced corrosive effect on certain metals than those of conventional art mixtures of the peracetic acid/peroxide types known to the applicants.
  • a stable, anticorrosive to surgical and dental metals concentrate including peracetic acid, acetic acid, hydrogen peroxide and purified water mixed in a ratio of from about one to eleven parts total acid to one part hydrogen peroxide.
  • the new concentrate has from substantially about .001 ppm to 200 ppm, more preferably from about .001 ppm to 100 ppm, and most preferably from about .001 ppm to 10 ppm of added stabilizers, such as phosphonic acids, sodium pyrophosphates and from about .001 - 10 ppm of ionic and non-ionic contaminants such as divalent and trivalent ions, with no added surfactants, such as ethoxylated decyl alcohols, sulfonate and sulfate types.
  • stabilizers such as phosphonic acids, sodium pyrophosphates
  • ionic and non-ionic contaminants such as divalent and trivalent ions
  • a stable, anticorrosive to surgical and dental metals use-dilution formulation including a concentrate consisting essentially of at equilibrium peracetic acid, acetic acid, hydrogen peroxide and an aqueous diluent. said concentrate characterized in having from about .001- 200 ppm of added stabilizers, from "about .001-10 ppm of ionic and nonionic contaminants and no added surfactants; and a purified aqueous diluent; wherein the concentrate is diluted in the aqueous diluent from about 20 to 40 times.
  • a process for preparing a sterilant concentrate as described above including the steps of introducing from about 17% by weight to about 40% by weight hydrogen peroxide into a mixing drum, the hydrogen peroxide having from about .001-200 ppm of added stabilizers; blending thereinto from about 10% by weight to about 16% by weight acetic acid; and adding a purified aqueous diluent having from about .001-10 ppm of divalent and trivalent ions; wherein the equilibrium concentration includes from about 16-38% by weight hydrogen peroxide; from about 2.5-9% by weight acetic acid; from about 1.5-6.0% by weight peracetic acid; and an aqueous diluent and wherein the equilibrium concentration is characterized in having from about .001-200 ppm of added stabilizers, from about .001-10 ppm of ionic and nonionic contaminants and no added surfactants.
  • One of the advantages of the present invention is that the occasional allergic reactions of some individuals to the conventional art formulations is reduced. Another advantage of the present invention is that the presence of mineral-like deposits from the use of the solutions of conventional art formulations containing sequestrants or stabilizers is no longer found. Perhaps most importantly, however, the present invention allows metal instruments such as dental tools and surgical instruments to be sterilized with significantly reduced corrosivity as will be shown. Further objects, features and advantages of the present invention will become apparent from the detailed description of the preferred embodiments, including the best mode, which follow.
  • Figure 1 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 4.1% by weight of peracetic acid and the storage temperature was at ambient temperature of 22'C;
  • Figure 2 is a chart of stability of concentrated microbicide where the initial formulation contained 4.5% by weight of peracetic acid and the storage temperature was 35'C;
  • Figure 3 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 4.2% by weight of peracetic acid and the storage temperature was 50 * C;
  • Figure 4 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 22 * C;
  • Figure 5 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 35'C;
  • Figure 6 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 50"C;
  • Figure 7 is a chart of
  • Concentrate microbicide formulations in accordance with the present invention possess the desirable property of a long storage life without deleterious decomposition despite the absence of conventional additions of stabilizers and sequestrants as heretofore taught in the art. Additionally, the concentrate compositions of the present invention are far less corrosive to metals that are sterilized using the compositions such as surgical and dental instruments. In contrast with conventional art formulations containing added surfactants, sequestrants and other stabilizers where visible evidence of corrosion of the metals appeared in one or two hours, formulations in accordance with the preferred embodiment of the present invention visibly showed comparatively little corrosion on the same metals during the same time period.
  • Manufacture of the preferred embodiment is effected by mixing a solution of hydrogen peroxide with acetic acid diluted with a purified aqueous diluent.
  • the hydrogen peroxide is selected from commercially available sources having low concentrations of stabilizers, preferably .001 ppm to 200 ppm, more preferably from about .001 ppm to 100 ppm, and most preferably from about .001 ppm to 15 ppm of added stabilizers, such as phosphonic acids, sodium pyrophosphates. Sources of such hydrogen peroxide are available from FMC Corporation (Philadelphia, PA) .
  • the preferred embodiment in accordance with the present invention preferably includes no contaminants.
  • Contaminants such as divalent and trivalent ions, principally, iron, manganese, magnesium, nickel and cobalt, and undesirable trace organics found in the manufacturing process, principally, surfactants, acetone, methanol, ethanol, which are typically present in conventional art formulations are found in the present invention in amounts preferably from about 5-10 ppm and most preferably from about .001-5 ppm in the final composition.
  • Table I the preferred composition is shown. TABLE I Initial Mixture After Equilibrium H 2 0 2 17-40% by wt. 16-38% by wt. HOAc 10-16% by wt. 2.5-9.0% by wt. HOOAc 0 1.5-6.0% by wt.
  • the concentrate microbicide in accordance with the present invention may be formulated over a wide range of concentrations of the active materials. After equilibrium the concentrate microbicide may have as high as 38% by weight hydrogen peroxide at equilibrium with the peracetic acid concentration ranging from 1.5% to 6.0% as indicated in Table 1. Since the concentrate when initially mixed contains no peracetic acid and therefore is not used immediately, it is stored for approxmately 19-20 days until the solution equilibrates and peracetic acid is formed by the reaction of hydrogen peroxide with acetic acid as illustrated in Reaction 1. Reaction 1 .
  • Brass coupons were placed on edge in a 50% by weight solution of HCl for two minutes at ambient temperature. Aluminum coupons were placed on edge in concentrated nitric acid for three minutes at ambient temperature. During all phases of the testing, coupons were handled by gloved laboratory personnel to insure that the coupons were not exposed to any foreign materials prior to placing them in the test solutions. All coupons are stamped with a number to aid in identification. All coupons were air dried under a ventilated hood and weighed prior to testing on a Mettler AE 100 analytical balance. The weight was recorded as the initial weight. The exposure time of the coupons was .5 hours for brass and 5 hours for aluminum when testing the concentrate microbicide and 5 hours for brass and 1 week for aluminum when testing the use-dilution formulation of the microbicide.
  • the coupons were tested in the test solutions indicated below at ambient temperature. Solution volumes of 70ml were dispensed into plastic disposable cups. The coupons were allowed to remain in solution for the times indicated above. After the time period had expired, the solution was discarded and the coupons were placed to dry, without rinsing, standing on edge in a ventilating hood. After drying for 30-60 minutes, the coupons were re-weighed.
  • the concentrate is shipped in a small quantity in an amber colored plastic bottle together with a gallon of purified deionized water.
  • the concentrate of the preferred embodiment is diluted from about 20 to 40 times, more preferably from about 25 to 35 times, and most preferably from about 30 to 33 times with a purified aqueous diluent prepared as described below. This results in a use-dilution formulation of approximately 3.0% to 4.5% by volume of concentrate.
  • Ordinary tap water is generally unsuitable as a diluent because of contaminants, such as divalent and trivalent ions, contained therein. If ordinary tap water is used to dilute the concentrate, the shelf life of the use-dilution formulation will likely be less than when the purified aqueous diluent is used and corrosivity will increase as the purity of the water decreases. The recommended shelf life of the use-dilution microbicide is seven days. Consequently, it may be used for several applications or reused several times during that period of time with no change in the stability or in the anticorrosive or sporicidal activity.
  • a purified aqueous diluent suitable for use in the concentrate and use-dilution formulation in accordance with the present invention is prepared in the following manner.
  • Raw city water is passed through an activated carbon bed containing 10 cubic feet of carbon in a 24 in. diameter fiberglass tank with a 2 in. diameter super flow head and a 2 in. diameter distributor.
  • the water is then passed through softening beds well known in the art of water purification to remove calcium chloride and magnesium. Suitable softening beds are available from Eco Water Systems (Woodbury, MN) .
  • the water is then passed through a one micron polypropylene cloth sediment filter having an efficiency rate of 93%.
  • the cloth filter catches any particulate matter remaining in the water that has a size greater than l u .
  • the water then flows through an eight inch diameter reverse osmosis membrane filter.
  • the membrane filter is made from a spirally wound polyamide sheet membrane and is commercially available as Model No.
  • the water effluent has less than 5 ppm dissolved solids .
  • the unit employs dual wave lengths at 185nm and 254nm and is rated at 99%.9 bacterial reduction.
  • a suitable commercially available unit is the Aquafine U.V. Water Sterilizer, CLS-4R (Aquafine Corp, Valencia, CA.) Post-UV light treatment, the water flows through an anion exchange resin bed and a cation exchange resin bed.
  • the anion exchange resin bed is a strongly basic anion exchange resin based on a styrenedivinylbenzene copolymer matrix. Its exchange capacity is derived from the »(CH 3 ) 2 H 4 ⁇ H (dimethylethanolamine) group.
  • Anion exchange resin bed capable of purifying the aqueous diluent in accordance with the present invention may be purchased from Sybron Chemicals Inc (Birmingham, N.J.) under the trade name IONAC ASB-2.
  • the cation exchange resin bed is a bead-form, standard crosslinked, polystyrene sulfonate cation exchange resin with a capacity of 1.4 mEq/ml for further demineralization.
  • Treated water is stored in a 1000-5000 gallon tank. Resistivity is constantly measured and maintained at 17-17.5 mOhms. Prior to using the above manufactured water in the concentrate mixtures or use-dilution formulations in accordance with the present invention, the water is tested for pyrogen, yeast, molds and bacteria by the following methods. Pyro ⁇ en Testing. Five milliliters of sterile water is pipetted into a vials of endotoxin, commercially available as endotoxin from E. coli strain 055.B5 from Whittaker Bioproducts, Inc. (Walkersville, MD) .
  • lysate Five and two-tenths milliliters of sterile water is pipetted into a vial of lysate, commercially available as Pyrogen T from hittaker Bioproducts. One hundred lambda of the reconstituted lysate is then pipetted into disposable conical tubes. The diluted lysate has a sensitivity of 0.06 endotoxin units. Serial dilutions of the reconstituted endotoxin ranging from 500 picograms/ml to 12.5 picograms/ml are prepared. Positive controls are set up by pipetting 100 lambda of each of the above prepared dilutions of endotoxin into a conical tube containing the lysate.
  • Tubes are mixed and placed in a 37° heating block for one hour ⁇ two minutes.
  • Triplicate samples of 100 lambda each of ultra-pure deionized water as manufactured in accordance with the procedure disclosed herein are added to the lysate tubes and incubated at 37°C for one hour.
  • a gelled tube indicates the presence of endotoxin.
  • Yeast. Molds and Bacteria Testing Water used in the manufacture of the concentrate microbicide and in the use-dilution formulation is tested for the presence of microbes using a filter membrane technique.
  • Samples are collected aseptically in sterile 10ml test tubes at the source. Five milliliters of sample is transfered into a 100ml filter housing. A vacuum is applied to the filter housing to facilitate filtration.
  • the lower housing is removed and the filtrate is decanted.
  • the filter membrane is aseptically removed and placed in a tryptone glucose yeast agar plate (DiMed Corporation, St. Paul, MN) for measuring bacterial growth and potato dextrose agar plates (DiMed Corporation, St. Paul, MN) for measuring yeast and mold growth.
  • the media plate is covered, inverted and incubated at 35°C for two days for bacteria and at 22°C for seven days for yeasts and molds. Results are reported as the number of colony forming units per five milliliters of sample size.
  • EXAMPLES Example 1 All mixing drums and tanks were thoroughly cleaned using purified water. Sixty percent by weight of purified water was added to a cleaned mixing tank at ambient temperature.
  • Bacterial testing and yeast and molds testing of the water used in manufacturing the concentrate was reported as 0 colony forming units per five milliliters of sample for both tests.
  • An air driven drum pump was turned on to start recirculation of the batch.
  • Fourteen percent by weight of acetic acid was added to the mixing tank containing the deionized water. Afcer the acetic acid was added, the batch was covered and recirculated for one hour.
  • 26% by weight of hydrogen peroxide was added into the mixing tank and the cover replaced.
  • the composition was recirculated for two hours after all chemicals were added. After two hours, the recirculating pump was stopped.
  • the concentrate was dispensed into clean 55 gallon drums for storage and equilibrated for 19 days.
  • Microbicidal Effectiveness A 3.0% solution of the concentrate microbicide manufacture in Example 1 was tested for sporicidal activity according to the methods outlined in the Official Methods of Analysis of the Association of Official Analytical Chemists (K. Helrich 15th ed. 1990) (966.04 pp. 141-142), the text of which is hereby specifically incorporated by reference. Briefly, cultures of two sporoformer organisms, Bacillus subtilis ATCC 19649 and Clostridium sporogenes ATCC 3584 were grown in the appropriate medium.
  • the results of the AOAC procedure reference test shows that the microbicide of the invention, in addition to being stable, is effective as a sterilant.
  • Example 3 The concentrate prepared in accordance with Example 2 was tested for corrosivity. The results are shown in Table IIA as Sample 2.
  • HOAc 8.143% by weight Bacterial testing and yeast and molds testing of the water used in manufacturing the concentrate was reported as 0 colony forming units per five milliliters of sample for both tests. After mixing for the specified time periods, the concentrate was allowed to stand for 19 days and a sample was taken to determine the content of H 2 0 2 and HOOAc.
  • the final concentration was determined to be 16.86% by weight H 2 0 2 , 1.66% peracetic acid and 6.26% acetic.
  • the solution was found to have microbicidal activity as follows:

Abstract

Stable microbicides comprising hydrogen peroxide, peracetic acid, acetic acid and purified water substantially free of contaminants, sequestrants or stabilizers and having anticorrosive properties for metals used in surgical and dental instruments is disclosed.

Description

STABLE, ANTICORROSIVE PERACETIC/PEROXIDE STERILANT Background, of the Invention l. Field of the Invention This invention relates generally to the field of microbicides. In particular, it relates to a stable microbicide having anticorrosive properties comprising a mixture of hydrogen peroxide, peracetic acid, acetic acid and purified water which is substantially free of contaminants or stabilizing and seguestrant type additives. 2. Description of the Related Art Peracetic acid/peroxide containing compositions have a long history of use as disinfectants and sterilizers due to their microbicidal activities. However, peroxide containing compositions are high-energy-state compounds and as such can be considered thermodynamically unstable. Therefore, because there is a strong tendency for these compositions to decompose in the presence of multivalent metal ions, stabilizers are added. Stabilizers may be agents such as sodium pyrophosphate, phosphonic acid or chelating agents such as 8-hydroxyquinoline. Stabilizers act by removing trace metals which accelerate the decomposition of peroxides. Stabilizers also accelerate the reaction between hydrogen peroxide and acetic acid to form peracetic acid. Therefore, for any given concentration of hydrogen proxide and acetic acid, the addition of a stabilizer increases the concentration at equilibrium of peracetic acid. While conventional art compositions are stable due to the use of added stabilizers, they are also highly corrosive to the very metals they are designed to disinfect namely surgical and dental instruments made of aluminum or brass, which instruments are often plated with an ornamental or protective layer of nickel or nickel and/or chromium. Additionally, certain susceptible individuals often exhibit allergic reactions to the conventional art formulations. Further, after prolonged use these conventional art formulations often leave mineral-like deposits on the metal instruments they sterilize. A concentrated composition that contains no stabilizer or sequestrant type additives that is both stable during storage for prolonged periods of time and possesses anticorrosive properties would be a decided advantage over these conventional formulations. Further, a use-dilution formulation that may be reused several times, is stable for relatively long periods in the diluted form and possesses anticorrosive properties would be a further advantage over conventional formulations. Summary of the Invention It is an object of the stable, anticorrosive concentrate and use-dilution microbicides in accordance with the present invention to solve the problems outlined above that has heretofore inhibited long-term storage and the anticorrosive sterilization of surgical and dental instruments. These improved microbicide solutions not only have the desired stability but have been shown to have a significantly reduced corrosive effect on certain metals than those of conventional art mixtures of the peracetic acid/peroxide types known to the applicants. In accomplishing the foregoing objectives, there has been provided in accordance with the present invention a stable, anticorrosive to surgical and dental metals concentrate including peracetic acid, acetic acid, hydrogen peroxide and purified water mixed in a ratio of from about one to eleven parts total acid to one part hydrogen peroxide. The new concentrate has from substantially about .001 ppm to 200 ppm, more preferably from about .001 ppm to 100 ppm, and most preferably from about .001 ppm to 10 ppm of added stabilizers, such as phosphonic acids, sodium pyrophosphates and from about .001 - 10 ppm of ionic and non-ionic contaminants such as divalent and trivalent ions, with no added surfactants, such as ethoxylated decyl alcohols, sulfonate and sulfate types. In accordance with another aspect of the present invention, there has been provided a stable, anticorrosive to surgical and dental metals use-dilution formulation including a concentrate consisting essentially of at equilibrium peracetic acid, acetic acid, hydrogen peroxide and an aqueous diluent. said concentrate characterized in having from about .001- 200 ppm of added stabilizers, from "about .001-10 ppm of ionic and nonionic contaminants and no added surfactants; and a purified aqueous diluent; wherein the concentrate is diluted in the aqueous diluent from about 20 to 40 times. In accordance with still another aspect of the present invention, there has been provided a process for preparing a sterilant concentrate as described above, including the steps of introducing from about 17% by weight to about 40% by weight hydrogen peroxide into a mixing drum, the hydrogen peroxide having from about .001-200 ppm of added stabilizers; blending thereinto from about 10% by weight to about 16% by weight acetic acid; and adding a purified aqueous diluent having from about .001-10 ppm of divalent and trivalent ions; wherein the equilibrium concentration includes from about 16-38% by weight hydrogen peroxide; from about 2.5-9% by weight acetic acid; from about 1.5-6.0% by weight peracetic acid; and an aqueous diluent and wherein the equilibrium concentration is characterized in having from about .001-200 ppm of added stabilizers, from about .001-10 ppm of ionic and nonionic contaminants and no added surfactants. One of the advantages of the present invention is that the occasional allergic reactions of some individuals to the conventional art formulations is reduced. Another advantage of the present invention is that the presence of mineral-like deposits from the use of the solutions of conventional art formulations containing sequestrants or stabilizers is no longer found. Perhaps most importantly, however, the present invention allows metal instruments such as dental tools and surgical instruments to be sterilized with significantly reduced corrosivity as will be shown. Further objects, features and advantages of the present invention will become apparent from the detailed description of the preferred embodiments, including the best mode, which follow. Brief Description of the Drawings Figure 1 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 4.1% by weight of peracetic acid and the storage temperature was at ambient temperature of 22'C; Figure 2 is a chart of stability of concentrated microbicide where the initial formulation contained 4.5% by weight of peracetic acid and the storage temperature was 35'C; Figure 3 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 4.2% by weight of peracetic acid and the storage temperature was 50*C; Figure 4 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 22*C; Figure 5 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 35'C; Figure 6 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide and the storage temperature was 50"C; Figure 7 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23% by weight of hydrogen peroxide, 4% by weight of peracetic acid and 8.4% acetic acid and the solution was stored at ambient temperature; Figure 8 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23.8% by weight hydrogen peroxide and 4.47% by weight peracetic acid and the solution was stored at ambient temperature; Figure 9 is a chart of stability of the concentrated microbicide against time where the initial formulation contained 23.8% by weight hydrogen peroxide and 4.47% peracetic acid and the storage temperature was 35°C; Figure 10 is a chart of stability of the concentrated microbicide where the initial formulation contained 23.8% by weight hydrogen peroxide and 4.47% by weight peracetic acid and the storage temperature was 50°C; Figure 11 is a chart of stability of the concentrated microbicide where the initial formulation contained 17.2% by weight hydrogen peroxide and 0.0% by weight peracetic acid and the solution was stored at ambient temperature; Figure 12 is a chart of stability of the concentrated microbicide where the initial formulation contained 36.46% by weight hydrogen peroxide and 0.0% by weight peracetic acid and the solution was stored at ambient temperature; Figure 13 is a chart of stability of the concentrated microbicide where the initial formulation contained 27.4% by weight hydrogen peroxide and 5.6% by weight peracetic acid and the solution was stored at ambient temperature; Figure 14 is a chart of stability of the concentrated microbicide where the initial formulation contained 27.4% by weight hydrogen peroxide and 5.3% by weight peracetic acid and the solution was stored at 50°C. Detailed Description of the Invention Concentrate microbicide formulations in accordance with the present invention possess the desirable property of a long storage life without deleterious decomposition despite the absence of conventional additions of stabilizers and sequestrants as heretofore taught in the art. Additionally, the concentrate compositions of the present invention are far less corrosive to metals that are sterilized using the compositions such as surgical and dental instruments. In contrast with conventional art formulations containing added surfactants, sequestrants and other stabilizers where visible evidence of corrosion of the metals appeared in one or two hours, formulations in accordance with the preferred embodiment of the present invention visibly showed comparatively little corrosion on the same metals during the same time period. Manufacture of the preferred embodiment is effected by mixing a solution of hydrogen peroxide with acetic acid diluted with a purified aqueous diluent. The hydrogen peroxide is selected from commercially available sources having low concentrations of stabilizers, preferably .001 ppm to 200 ppm, more preferably from about .001 ppm to 100 ppm, and most preferably from about .001 ppm to 15 ppm of added stabilizers, such as phosphonic acids, sodium pyrophosphates. Sources of such hydrogen peroxide are available from FMC Corporation (Philadelphia, PA) . In addition, the preferred embodiment in accordance with the present invention preferably includes no contaminants. Contaminants such as divalent and trivalent ions, principally, iron, manganese, magnesium, nickel and cobalt, and undesirable trace organics found in the manufacturing process, principally, surfactants, acetone, methanol, ethanol, which are typically present in conventional art formulations are found in the present invention in amounts preferably from about 5-10 ppm and most preferably from about .001-5 ppm in the final composition. Referring to Table I, the preferred composition is shown. TABLE I Initial Mixture After Equilibrium H202 17-40% by wt. 16-38% by wt. HOAc 10-16% by wt. 2.5-9.0% by wt. HOOAc 0 1.5-6.0% by wt. The concentrate microbicide in accordance with the present invention may be formulated over a wide range of concentrations of the active materials. After equilibrium the concentrate microbicide may have as high as 38% by weight hydrogen peroxide at equilibrium with the peracetic acid concentration ranging from 1.5% to 6.0% as indicated in Table 1. Since the concentrate when initially mixed contains no peracetic acid and therefore is not used immediately, it is stored for approxmately 19-20 days until the solution equilibrates and peracetic acid is formed by the reaction of hydrogen peroxide with acetic acid as illustrated in Reaction 1. Reaction 1 . CH3C02H + H202 _^ CH3CO3H + H20 The concentrate manufactured in accordance with the present invention is stored and shipped in amber colored plastic bottles that have been thoroughly precleaned with purified water to ensure no heavy metal contamination. Stability studies were run at ambient (22*C), 35'C and 50'C to determine the stability of the concentrate over time at these temperatures. Data regarding the relative stability of H202 and HOOAc in the concentrate composition and the concentrate itself are shown in Figures 1-14. Acetic acid typically was not measured for stability since it is not one of the active ingredients of the concentrate composition; in other words, acetic acid has no icrobicidal activity. As can be seen from Figures 1-15, the solutions were very stable. In addition to stability studies, corrosivity studies were run on the concentrate compositions, the results of which may be seen by referring to Table IIA. Table IIB details the results of the corrosivity run on conventional art formulations while Table IIC details the results of corrosivity testing on the component parts of the conventional art formulation. Table IID details the results of corrosivity studies run on the use- dilution formulations of the conventional art and several of the preferred embodiments of the present invention. Corrosivity studies were done using a variety of metal coupons. They included naval brass 464 and aluminum 5052. The coupons are commercially available from Metal Samples Company (Munford, Al.) Coupons were cleaned by the following methods to remove all foreign debris and to ensure accurate results. Brass coupons were placed on edge in a 50% by weight solution of HCl for two minutes at ambient temperature. Aluminum coupons were placed on edge in concentrated nitric acid for three minutes at ambient temperature. During all phases of the testing, coupons were handled by gloved laboratory personnel to insure that the coupons were not exposed to any foreign materials prior to placing them in the test solutions. All coupons are stamped with a number to aid in identification. All coupons were air dried under a ventilated hood and weighed prior to testing on a Mettler AE 100 analytical balance. The weight was recorded as the initial weight. The exposure time of the coupons was .5 hours for brass and 5 hours for aluminum when testing the concentrate microbicide and 5 hours for brass and 1 week for aluminum when testing the use-dilution formulation of the microbicide. The coupons were tested in the test solutions indicated below at ambient temperature. Solution volumes of 70ml were dispensed into plastic disposable cups. The coupons were allowed to remain in solution for the times indicated above. After the time period had expired, the solution was discarded and the coupons were placed to dry, without rinsing, standing on edge in a ventilating hood. After drying for 30-60 minutes, the coupons were re-weighed. The difference between the initial weight and final weight (W) was used to calculated the corrosion rate as follows: Corrosion rate (mm/yr) = (K x W) where: (A x T x D) K = a constant (8.76 x 10~4) T = time of exposure in hours "A = area in cm-2 (28.7 cm-2) W = weight loss in grams (initial weight - final weight)* *To correct for possible weight loss due to product removal, a "blank" coupon was weighed, cleaned by the procedure indicated above and weighed again. D = density in g/cπr3** **Brass = 8.41 g/cm-3 Aluminum 5052 = 2.68 g/cm-3
TABLE IIA Titrations Samples EkQ-t PAA HoAc 1 38.8% 4.54% 2.88% 2 34.8% 4.23% 3.27%
Figure imgf000011_0001
Figure imgf000012_0001
In the present preferred form of the invention, the concentrate is shipped in a small quantity in an amber colored plastic bottle together with a gallon of purified deionized water. Before use, the concentrate of the preferred embodiment is diluted from about 20 to 40 times, more preferably from about 25 to 35 times, and most preferably from about 30 to 33 times with a purified aqueous diluent prepared as described below. This results in a use-dilution formulation of approximately 3.0% to 4.5% by volume of concentrate. Ordinary tap water is generally unsuitable as a diluent because of contaminants, such as divalent and trivalent ions, contained therein. If ordinary tap water is used to dilute the concentrate, the shelf life of the use-dilution formulation will likely be less than when the purified aqueous diluent is used and corrosivity will increase as the purity of the water decreases. The recommended shelf life of the use-dilution microbicide is seven days. Consequently, it may be used for several applications or reused several times during that period of time with no change in the stability or in the anticorrosive or sporicidal activity. A purified aqueous diluent suitable for use in the concentrate and use-dilution formulation in accordance with the present invention is prepared in the following manner. Raw city water is passed through an activated carbon bed containing 10 cubic feet of carbon in a 24 in. diameter fiberglass tank with a 2 in. diameter super flow head and a 2 in. diameter distributor. The water is then passed through softening beds well known in the art of water purification to remove calcium chloride and magnesium. Suitable softening beds are available from Eco Water Systems (Woodbury, MN) . The water is then passed through a one micron polypropylene cloth sediment filter having an efficiency rate of 93%. The cloth filter catches any particulate matter remaining in the water that has a size greater than lu. The water then flows through an eight inch diameter reverse osmosis membrane filter. The membrane filter is made from a spirally wound polyamide sheet membrane and is commercially available as Model No. BW-30 from Filmtec Co. (Edina, MN) . The water effluent has less than 5 ppm dissolved solids . After the water is treated by passing it through the reverse osmosis membrane, it is circulated through an ultraviolet disinfection unit. The unit employs dual wave lengths at 185nm and 254nm and is rated at 99%.9 bacterial reduction. A suitable commercially available unit is the Aquafine U.V. Water Sterilizer, CLS-4R (Aquafine Corp, Valencia, CA.) Post-UV light treatment, the water flows through an anion exchange resin bed and a cation exchange resin bed. The anion exchange resin bed is a strongly basic anion exchange resin based on a styrenedivinylbenzene copolymer matrix. Its exchange capacity is derived from the »(CH3)2H4θH (dimethylethanolamine) group. Anion exchange resin bed capable of purifying the aqueous diluent in accordance with the present invention may be purchased from Sybron Chemicals Inc (Birmingham, N.J.) under the trade name IONAC ASB-2. The cation exchange resin bed is a bead-form, standard crosslinked, polystyrene sulfonate cation exchange resin with a capacity of 1.4 mEq/ml for further demineralization. Treated water is stored in a 1000-5000 gallon tank. Resistivity is constantly measured and maintained at 17-17.5 mOhms. Prior to using the above manufactured water in the concentrate mixtures or use-dilution formulations in accordance with the present invention, the water is tested for pyrogen, yeast, molds and bacteria by the following methods. Pyroσen Testing. Five milliliters of sterile water is pipetted into a vials of endotoxin, commercially available as endotoxin from E. coli strain 055.B5 from Whittaker Bioproducts, Inc. (Walkersville, MD) . Five and two-tenths milliliters of sterile water is pipetted into a vial of lysate, commercially available as Pyrogen T from hittaker Bioproducts. One hundred lambda of the reconstituted lysate is then pipetted into disposable conical tubes. The diluted lysate has a sensitivity of 0.06 endotoxin units. Serial dilutions of the reconstituted endotoxin ranging from 500 picograms/ml to 12.5 picograms/ml are prepared. Positive controls are set up by pipetting 100 lambda of each of the above prepared dilutions of endotoxin into a conical tube containing the lysate. Tubes are mixed and placed in a 37° heating block for one hour ± two minutes. Triplicate samples of 100 lambda each of ultra-pure deionized water as manufactured in accordance with the procedure disclosed herein are added to the lysate tubes and incubated at 37°C for one hour. A gelled tube indicates the presence of endotoxin. Yeast. Molds and Bacteria Testing Water used in the manufacture of the concentrate microbicide and in the use-dilution formulation is tested for the presence of microbes using a filter membrane technique. Samples are collected aseptically in sterile 10ml test tubes at the source. Five milliliters of sample is transfered into a 100ml filter housing. A vacuum is applied to the filter housing to facilitate filtration. The lower housing is removed and the filtrate is decanted. The filter membrane is aseptically removed and placed in a tryptone glucose yeast agar plate (DiMed Corporation, St. Paul, MN) for measuring bacterial growth and potato dextrose agar plates (DiMed Corporation, St. Paul, MN) for measuring yeast and mold growth. The media plate is covered, inverted and incubated at 35°C for two days for bacteria and at 22°C for seven days for yeasts and molds. Results are reported as the number of colony forming units per five milliliters of sample size. EXAMPLES Example 1 All mixing drums and tanks were thoroughly cleaned using purified water. Sixty percent by weight of purified water was added to a cleaned mixing tank at ambient temperature. Bacterial testing and yeast and molds testing of the water used in manufacturing the concentrate was reported as 0 colony forming units per five milliliters of sample for both tests. An air driven drum pump was turned on to start recirculation of the batch. Fourteen percent by weight of acetic acid was added to the mixing tank containing the deionized water. Afcer the acetic acid was added, the batch was covered and recirculated for one hour. Using an air driven drum pump, 26% by weight of hydrogen peroxide was added into the mixing tank and the cover replaced. The composition was recirculated for two hours after all chemicals were added. After two hours, the recirculating pump was stopped. The concentrate was dispensed into clean 55 gallon drums for storage and equilibrated for 19 days. After 19 days from the production date, a sample was taken from the concentrate batch and the concentration was determined to be 22.5% H202, 3.96% peracetic acid, and 8.1% acetic acid. Microbicidal Effectiveness A 3.0% solution of the concentrate microbicide manufacture in Example 1 was tested for sporicidal activity according to the methods outlined in the Official Methods of Analysis of the Association of Official Analytical Chemists (K. Helrich 15th ed. 1990) (966.04 pp. 141-142), the text of which is hereby specifically incorporated by reference. Briefly, cultures of two sporoformer organisms, Bacillus subtilis ATCC 19659 and Clostridium sporogenes ATCC 3584 were grown in the appropriate medium. Each organism was used to contaminate two types of carriers, namely, silk suture and porcelain penicylinders. The carriers were dried for a minimum of 24 hrs. under vacuum. Carriers were tested for acid resistance and viability. Five carriers were placed in test tubes containing 10 itiL. of test solution, and exposed for 30 min. at 50°C. Following contact, carriers were neutralized in thioglycollate medium and incubated for 21 days at 37°C. If no growth was observed after 21 days, the test tubes were heat shocked for 20 minutes at 80°C to activate any remaining spores and incubated for 72 hrs. at 37°C. For chemical sterilant claims, no survival of any organism/spore can be tolerated for qualification of the solution by the U.S. Environmental Protection Agency as a sterilant. The results of the sporicidal testing of the concentrate microbicide in accordance with the microbicide prepared in Example 1 are as follows: Lot Org . Carrier Titer
2M00 2M004 2M004 2M00
Figure imgf000017_0001
Figure imgf000017_0002
The results of the AOAC procedure reference test shows that the microbicide of the invention, in addition to being stable, is effective as a sterilant.
Corrosivity of the solution of Example 1 was tested. The results appear as Sample 15 in Table IIA.
Example 2
All mixing drums and tanks were thoroughly cleaned using purified water. 23.3% by weight of purified water was added to a cleaned mixing tank at ambient temperature. Bacterial testing and yeast and molds testing of the water used in manufacturing the concentrate was reported as 0 colony forming units per five milliliters of sample for both tests. An air driven drum pump was turned on to start recirculation of the batch. 16.7% by weight of acetic acid was added to the mixing tank containing the purified water. After the acetic acid was added, the batch was covered and recirculated for one hour. Using an air driven drum pump, 40.0% by weight of hydrogen peroxide was added into the mixing tank and the cover replaced. The composition was recirculated for two hours after all chemicals were added. After two hours, the recirculating pump was stopped. The concentrate was dispensed into clean 55 gallon drums for storage. After 19 days from the production date, the batch was adjusted to a hydrogen peroxide level of 36.5% and a peracetic acid level of 4.5% by adding water and hydrogen peroxide. The solution was allowed to equilibrate for an additional 33 days. A sample was taken from the concentrate batch and the concentration was determined to be 36.65% hydrogen peroxide, 4.31% peracetic acid and 2.88%. The results of the sporicidal testing of a 3% solution of the concentrate microbicide in accordance with the microbicide prepared in Example 2 are as follows: Lot Org. Carrier Titer
Figure imgf000018_0002
Figure imgf000018_0001
The concentrate prepared in accordance with Example 2 was tested for corrosivity. The results are shown in Table IIA as Sample 2. Example 3
Using the method set forth in Examples 1 and 2, 7.74% by weight purified water was added to 17.12% by weight H0 and
8.143% by weight HOAc. Bacterial testing and yeast and molds testing of the water used in manufacturing the concentrate was reported as 0 colony forming units per five milliliters of sample for both tests. After mixing for the specified time periods, the concentrate was allowed to stand for 19 days and a sample was taken to determine the content of H202 and HOOAc.
The final concentration was determined to be 16.86% by weight H202, 1.66% peracetic acid and 6.26% acetic. The solution was found to have microbicidal activity as follows:
Lot Org. Carrier Titer Resistance #Survivors/ #Tested
2028-1 10 min. 0/60 2028-1 10 min. 0/60 2028-1 10 min. 0/60 2028-1
Figure imgf000018_0003
2 min. 0/60
Corrosivity was tested and the results are detailed in Table IIA as Sample 18.
While the preceding compositions in accordance with the invention are the preferred form it is to be understood that concentrate formulations 'may be within the ranges given and still provide the advantages of the invention. Those skilled in the art may recognize other equivalents to the specific embodiments described herein which equivalents are intended to be encompassed by the appended claims.

Claims

We claim: 1. A stable, anticorrosive to surgical and dental metals concentrate consisting essentially of at equilibrium peracetic acid, acetic acid, hydrogen peroxide and an aqueous diluent, said concentrate characterized in having from about .001-200 ppm of added stabilizers, from about .001-10 ppm of ionic and nonionic contaminants and no added surfactants. 2. The concentrate in accordance with Claim 1 wherein the concentration of added stabilizer is from about .001- 100 ppm. 3. The concentrate is accordance with Claim 1 wherein the concentration of added stabilizer is from about .001- 10 ppm. 4. The concentrate of Claim 1 wherein the equilibrium composition comprises: a) H202 16 to 38% by weight; b) HOAc 2.5 to 9.0% by weight; c) HOOAc 1.5 to 6.0% by weight; and d) the balance is a purified aqueous diluent. 5. The concentrate in accordance with Claim 4 wherein the concentration of added stabilizer is from about .001- 100 ppm. 6. The concentrate in accordance with Claim 4 wherein the concentration of added stabilizer is from about .001- 10 ppm. 7. The concentrate in accordance with Claim 1 wherein the equilibrium concentration comprises: a) H202 23 to 24% by weight; b) HOAc 9 to 10% by weight; c) HOOAc 4 to 6% by weight; and d) the balance is a purified aqueous diluent. 8. The concentrate in accordance with Claim 7 wherein the concentration of added stabilizer is from about .001- 100 ppm. 9. The concentrate in accordance with Claim 7 wherein the concentration of added stabilizer is from about .001- 10 ppm. 10. A method of formulating a stable, anticorrosive to surgical and dental metals concentrate microbicide comprising the steps of: a) blending hydrogen peroxide, acetic acid and a purified aqueous diluent to result in a solution which at equilibrium has from about .001-200 ppm added stabilizers, from about .001-10 ppm of ionic and nonionic contaminants and no added surfactants. 11. A method of formulating a stable, anticorrosive to surgical and dental metals concentrate microbicide comprising the steps of: a) introducing from about 17% by weight to about 40% by weight hydrogen peroxide into a mixing drum, said hydrogen peroxide having from about .001-200 ppm of added stabilizers; and b) blending thereinto from about 10% by weight to about 16% by weight acetic acid; and c) adding a purified aqueous diluent having from about .001-10 ppm of divalent and trivalent ions; wherein the equilibrium concentration comprises: i) from about 16-38% by weight hydrogen peroxide; ii) from about 2.5-9% by weight acetic acid; iii) from about 1.5-6.0% by weight peracetic acid; and iv) an aqueous diluent wherein said equilibrium concentration is characterized in having from about .001-200 ppm of added stabilizers, from about .001-10 ppm of ionic and nonionic contaminants and no added surfactants. 12. A stable, anticorrosive to surgical and dental metals use-dilution microbicide comprising: a) a concentrate consisting essentially of at equilibrium peracetic acid, acetic acid, hydrogen peroxide and an aqueous diluent, said concentrate characterized in having from about .001- 200 ppm of added stabilizers, from about .001- 10 ppm of ionic and nonionic contaminants and no added surfactants; and b) a purified aqueous diluent; wherein said concentrate is diluted in said aqueous diluent from about 20 to 40 times.
PCT/US1992/005877 1991-07-15 1992-07-14 Stable, anticorrosive peracetic/peroxide sterilant WO1993001822A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU24100/92A AU661862B2 (en) 1991-07-15 1992-07-14 Stable, anticorrosive peracetic/peroxide sterilant
DE69231686T DE69231686T2 (en) 1991-07-15 1992-07-14 STABLE, ANTICORROSIVE PERESSIG- / PEROXID-STERILI-SATIONAL
US08/162,065 US5508046A (en) 1991-07-15 1992-07-14 Stable, anticorrosive peracetic/peroxide sterilant
BR9206266A BR9206266A (en) 1991-07-15 1992-07-14 Stable peracetic / anti-corrosion peroxide sterilizer.
JP5502905A JP2523085B2 (en) 1991-07-15 1992-07-14 Stable, corrosion-resistant peracetic acid / peroxide sterilant
EP92916914A EP0649310B1 (en) 1991-07-15 1992-07-14 Stable, anticorrosive peracetic/peroxide sterilant
AT92916914T ATE199058T1 (en) 1991-07-15 1992-07-14 STABLE, ANTI-CORROSIVE PERACETIC ACID/PEROXIDE STERILANT
DK92916914T DK0649310T3 (en) 1991-07-15 1992-07-14 Stable, anticorrosive peracetic acid / peroxide sterilizer
GR20010400504T GR3035654T3 (en) 1991-07-15 2001-03-29 Stable, anticorrosive peracetic/peroxide sterilant.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9104979 1991-07-15
USPCT/US91/04979 1991-07-15

Publications (1)

Publication Number Publication Date
WO1993001822A1 true WO1993001822A1 (en) 1993-02-04

Family

ID=22225675

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/005877 WO1993001822A1 (en) 1991-07-15 1992-07-14 Stable, anticorrosive peracetic/peroxide sterilant

Country Status (13)

Country Link
US (1) US5508046A (en)
EP (1) EP0649310B1 (en)
JP (1) JP2523085B2 (en)
AT (1) ATE199058T1 (en)
AU (1) AU661862B2 (en)
BR (1) BR9206266A (en)
CA (1) CA2113360C (en)
DE (1) DE69231686T2 (en)
DK (1) DK0649310T3 (en)
ES (1) ES2155824T3 (en)
GR (1) GR3035654T3 (en)
RU (1) RU2127607C1 (en)
WO (1) WO1993001822A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324524A (en) * 1997-04-22 1998-10-28 Samsung Electronics Co Ltd Sterilizing composition for ultrapure water
WO2002032228A2 (en) * 2000-10-17 2002-04-25 Bayer Corporation Process for inhibiting the growth of microorganisms in a pesticide suspension
EP3983087A4 (en) * 2019-06-14 2023-06-28 Armis Biopharma, Inc. Compositions for cleansing removable dental prosthetics
US11839213B2 (en) 2008-11-20 2023-12-12 Armis Biopharma, Inc. Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656302A (en) * 1987-05-14 1997-08-12 Minntech Corporation Stable, shippable, peroxy-containing microbicide
GB9122048D0 (en) * 1991-10-17 1991-11-27 Interox Chemicals Ltd Compositions and uses thereof
GB9300366D0 (en) * 1993-01-09 1993-03-03 Solvay Interox Ltd Compositions and uses thereof
US5871692A (en) * 1997-01-14 1999-02-16 Steris Corporation Method and apparatus for cleaning, decontaminating, and sterilizing catheters
US5977403A (en) * 1997-08-04 1999-11-02 Fmc Corporation Method for the production of lower organic peracids
WO1999011202A1 (en) * 1997-09-05 1999-03-11 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
US6039921A (en) * 1997-11-25 2000-03-21 Boucher; Raymond M. G. Liquid phase disinfection/sterilization with microwave energy
US6569353B1 (en) 1998-06-11 2003-05-27 Lynntech, Inc. Reactive decontamination formulation
US6010729A (en) 1998-08-20 2000-01-04 Ecolab Inc. Treatment of animal carcasses
WO2000018228A1 (en) 1998-10-01 2000-04-06 Minntech Corporation Multi-part anti-microbial sterilization compositions and methods
AU1827600A (en) 1998-11-23 2000-06-13 Ecolab Inc. Non-corrosive sterilant composition
US6352837B1 (en) 1999-02-22 2002-03-05 3M Innovative Properties Company Rapid readout sterilization indicator for liquid peracetic acid sterilization procedures
US6261457B1 (en) 1999-11-12 2001-07-17 Minntech Corporation Method and product for cleaning hollow fiber material and filter
KR100363896B1 (en) * 2000-04-21 2002-12-16 이진식 A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution
CA2407098C (en) * 2000-04-28 2009-12-29 Ecolab Inc. Antimicrobial composition
US7150884B1 (en) * 2000-07-12 2006-12-19 Ecolab Inc. Composition for inhibition of microbial growth
US6479454B1 (en) 2000-10-05 2002-11-12 Ecolab Inc. Antimicrobial compositions and methods containing hydrogen peroxide and octyl amine oxide
US6514556B2 (en) * 2000-12-15 2003-02-04 Ecolab Inc. Method and composition for washing poultry during processing
US7316824B2 (en) * 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
US6964787B2 (en) * 2001-02-01 2005-11-15 Ecolab Inc. Method and system for reducing microbial burden on a food product
US20030167506A1 (en) * 2001-03-22 2003-09-04 Pioneer Hi-Bred International, Inc. Expansin protein and polynucleotides and methods of use
US6635286B2 (en) * 2001-06-29 2003-10-21 Ecolab Inc. Peroxy acid treatment to control pathogenic organisms on growing plants
US7060301B2 (en) 2001-07-13 2006-06-13 Ecolab Inc. In situ mono-or diester dicarboxylate compositions
US20030129254A1 (en) * 2001-07-13 2003-07-10 Saraya Co., Ltd., A Japanese Corporation Bactericidal/disinfectant peracetic and acid composition
US6627593B2 (en) 2001-07-13 2003-09-30 Ecolab Inc. High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them
KR100515928B1 (en) * 2002-08-28 2005-09-20 이진식 A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1
KR100515929B1 (en) * 2002-08-28 2005-09-20 이진식 A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2
US7622606B2 (en) * 2003-01-17 2009-11-24 Ecolab Inc. Peroxycarboxylic acid compositions with reduced odor
US8999175B2 (en) * 2004-01-09 2015-04-07 Ecolab Usa Inc. Methods for washing and processing fruits, vegetables, and other produce with medium chain peroxycarboxylic acid compositions
US7771737B2 (en) * 2004-01-09 2010-08-10 Ecolab Inc. Medium chain peroxycarboxylic acid compositions
BRPI0506713A (en) * 2004-01-09 2007-05-02 Ecolab Inc medium chain peroxycarboxylic acid compositions
US20050161636A1 (en) * 2004-01-09 2005-07-28 Ecolab Inc. Methods for washing and processing fruits, vegetables, and other produce with medium chain peroxycarboxylic acid compositions
US7507429B2 (en) * 2004-01-09 2009-03-24 Ecolab Inc. Methods for washing carcasses, meat, or meat products with medium chain peroxycarboxylic acid compositions
US7887641B2 (en) * 2004-01-09 2011-02-15 Ecolab Usa Inc. Neutral or alkaline medium chain peroxycarboxylic acid compositions and methods employing them
US7504123B2 (en) * 2004-01-09 2009-03-17 Ecolab Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US20050220665A1 (en) * 2004-04-05 2005-10-06 Ding Lambert L Low temperature sterilization and disinfections method and apparatus for medical apparatus and instruments
US8110538B2 (en) * 2005-01-11 2012-02-07 Biomed Protect, Llc Peracid/peroxide composition and use thereof as an anti-microbial and a photosensitizer
US7553805B2 (en) * 2005-02-25 2009-06-30 Solutions Biomed, Llc Methods and compositions for treating viral, fungal, and bacterial infections
US7504369B2 (en) * 2005-02-25 2009-03-17 Solutions Biomed, Llc Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds
US7507701B2 (en) * 2005-02-25 2009-03-24 Solutions Biomed, Llc Aqueous disinfectants and sterilants including transition metals
US7462590B2 (en) * 2005-02-25 2008-12-09 Solutions Biomed, Llc Aqueous disinfectants and sterilants comprising a peroxide/peracid/transition metal mixture
US7534756B2 (en) * 2005-02-25 2009-05-19 Solutions Biomed, Llc Devices, systems, and methods for dispensing disinfectant solutions comprising a peroxygen and transition metal
US7511007B2 (en) * 2005-02-25 2009-03-31 Solutions Biomed, Llc Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
CA2599010C (en) 2005-02-25 2014-02-04 Solutions Biomed, Llc Aqueous disinfectants and sterilants
US7473675B2 (en) * 2005-02-25 2009-01-06 Solutions Biomed, Llc Disinfectant systems and methods comprising a peracid, alcohol, and transition metal
US7754670B2 (en) * 2005-07-06 2010-07-13 Ecolab Inc. Surfactant peroxycarboxylic acid compositions
EP1928586A4 (en) 2005-09-27 2010-01-06 Siemens Water Tech Corp Chemical cleaning agent and process for cleaning filtration membranes
US20070184155A1 (en) * 2006-02-06 2007-08-09 Harvey Michael S Antimicrobial ice compositions, methods of preparation, and methods of use
US7547421B2 (en) * 2006-10-18 2009-06-16 Ecolab Inc. Apparatus and method for making a peroxycarboxylic acid
US8075857B2 (en) 2006-10-18 2011-12-13 Ecolab Usa Inc. Apparatus and method for making a peroxycarboxylic acid
US20100075006A1 (en) * 2007-08-06 2010-03-25 Delaval Holding Ab Antimicrobial Process Using Peracetic Acid During Whey Processing
WO2009032203A1 (en) * 2007-08-30 2009-03-12 Solutions Biomed, Llc Colloidal metal-containing skin sanitizer
WO2009114754A1 (en) * 2008-03-14 2009-09-17 Solutions Biomed, Llc Multi-chamber container system for storing and mixing fluids
US8789716B2 (en) * 2008-11-12 2014-07-29 Solutions Biomed, Llc Multi-chamber container system for storing and mixing liquids
WO2010056871A2 (en) 2008-11-12 2010-05-20 Solutions Biomed, Llc Two-part disinfectant system and related methods
US20100120913A1 (en) * 2008-11-12 2010-05-13 Larson Brian G Resin catalyzed and stabilized peracid compositions and associated methods
US20110177148A1 (en) * 2009-07-27 2011-07-21 E. I. Du Pont De Nemours And Company Enzymatic in situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
AU2010281409B2 (en) 2009-07-27 2014-08-14 The Chemours Company Fc, Llc Enzymatic in situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
US11284621B2 (en) 2010-04-15 2022-03-29 Armis Biopharma, Inc. Compositions comprising peroxyacid and methods for producing and using the same
US20140308162A1 (en) 2013-04-15 2014-10-16 Ecolab Usa Inc. Peroxycarboxylic acid based sanitizing rinse additives for use in ware washing
US9752105B2 (en) 2012-09-13 2017-09-05 Ecolab Usa Inc. Two step method of cleaning, sanitizing, and rinsing a surface
US9283202B2 (en) 2012-10-18 2016-03-15 Chd Bioscience, Inc. Stable peracid-containing compositions
US20140314738A1 (en) * 2013-04-18 2014-10-23 Ya-Chung Wei Disinfecting composition
CN103704264B (en) * 2014-01-09 2016-04-20 南通思锐生物科技有限公司 A kind of disinfectant detergent
US10869479B2 (en) 2014-04-28 2020-12-22 American Sterilizer Company Wipe for killing spores
US10463754B2 (en) 2014-04-28 2019-11-05 American Sterilizer Company Process for decontaminating or sterilizing an article
US10750749B2 (en) * 2014-04-28 2020-08-25 American Sterilizer Company Process and composition for killing spores
US20210077438A1 (en) * 2017-07-07 2021-03-18 Armis Biopharma, Inc. Compositions and methods for remediating chemical warfare agent exposure and surface decontamination
CA3091170A1 (en) 2018-02-14 2019-08-22 Ecolab Usa Inc. Compositions and methods for the reduction of biofilm and spores from membranes
KR102034095B1 (en) 2018-07-02 2019-10-18 남일 Sterilization disinfection composition, method for producing the same and it’s metal corrosion prevention and stabilizing method
WO2020069079A1 (en) * 2018-09-27 2020-04-02 Medivators Inc. Peracetic acid stabilized compositions with stable lining
US20220071201A1 (en) * 2018-09-27 2022-03-10 Medivators Inc. Peracetic acid stabilized compositions with polymeric resins chelators
WO2022208944A1 (en) * 2021-04-02 2022-10-06 株式会社片山化学工業研究所 Method for preventing adherence of marine organisms etc.
JP7168278B1 (en) * 2021-04-02 2022-11-09 株式会社片山化学工業研究所 Method for preventing adhesion of marine organisms and anti-adhesion agent for marine organisms
JP7140343B1 (en) * 2021-04-02 2022-09-21 株式会社片山化学工業研究所 Method for preventing adherence of marine organisms, etc.
EP4337010A1 (en) * 2021-05-10 2024-03-20 Medivators Inc. Liquid chemical sterilization chemistry

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7608266A (en) * 1975-08-16 1977-02-18 Henkel & Cie Gmbh CONCENTRATES OF MICROBICIDE AGENTS.
NL7608265A (en) * 1975-08-16 1977-02-18 Henkel & Cie Gmbh STABLE CONCENTRATES OF FUNCTIONAL RESOURCES IN STORAGE.
CA1146851A (en) * 1978-05-01 1983-05-24 Donald F. Greene Hydrogen peroxide disinfecting and sterilizing compositions
DE3134050A1 (en) * 1981-08-28 1983-03-10 Dr. Franz Köhler Chemie GmbH, 6146 Alsbach Solution for sterilising and removing pyrogens from stainless steel lines and filters in a closed system
FR2521991A1 (en) * 1982-02-24 1983-08-26 Air Liquide COMMERCIAL SOLUTIONS OF STABLE AND NON-CORROSIVE CARBOXYLIC PERACIDS AND THEIR APPLICATIONS
US4971782A (en) * 1983-09-14 1990-11-20 Peroxydent Group Periodontal composition and method
GB8334249D0 (en) * 1983-12-22 1984-02-01 Tenneco Organics Ltd Disinfectants
FR2578332B1 (en) * 1985-01-30 1989-03-31 Air Liquide ASEPTISAN COMPOSITION FOR CONTACT LENSES
DE3529683A1 (en) * 1985-08-20 1987-02-26 Monforts Gmbh & Co A TENSION FRAME CHAIN
US4963157A (en) * 1987-04-17 1990-10-16 Nippon Peroxide Co., Ltd. Method for bleaching cellulosic fiber material with hydrogen peroxide
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
ATE102436T1 (en) * 1987-05-14 1994-03-15 Minntech Corp STABLE, TRANSPORTABLE, PEROXY CONTAINING MICROBICIDE.
DE3826442A1 (en) * 1988-08-03 1990-02-08 Royocad Ges Fuer Hard Und Soft PROJECTION HEAD
FR2639233B1 (en) * 1988-11-23 1994-05-06 Air Liquide HEMODIALYSIS HYGIENE AGENT
US5008106A (en) * 1989-12-14 1991-04-16 Gaf Chemicals Corporation Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2
DE69024503T2 (en) * 1990-04-05 1996-05-15 Minntech Corp ANTI-CORROSIVE MICROBICIDES

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACT, Volume 110, No. 22, issued 29 May 1989, L. COSENTINO, "Stable Microbiocides Containing Hydrogen Peroxide and Acetic Acid and Peracetic Acid", see Abstract No. 199231u. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324524A (en) * 1997-04-22 1998-10-28 Samsung Electronics Co Ltd Sterilizing composition for ultrapure water
GB2324524B (en) * 1997-04-22 1999-09-01 Samsung Electronics Co Ltd Sterilizing composition for making ultrapure water in the semiconductor devices fabrication process, method of sterilizing a ultrapure water delivery system
WO2002032228A2 (en) * 2000-10-17 2002-04-25 Bayer Corporation Process for inhibiting the growth of microorganisms in a pesticide suspension
WO2002032228A3 (en) * 2000-10-17 2002-10-03 Bayer Ag Process for inhibiting the growth of microorganisms in a pesticide suspension
US6716457B1 (en) 2000-10-17 2004-04-06 Bayer Polymers Llc Effects of bactericide (peracetic acid-hydrogen peroxide-water combination) to agricultural chemicals in bacteria control when they are in contact with one another
US11839213B2 (en) 2008-11-20 2023-12-12 Armis Biopharma, Inc. Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
EP3983087A4 (en) * 2019-06-14 2023-06-28 Armis Biopharma, Inc. Compositions for cleansing removable dental prosthetics

Also Published As

Publication number Publication date
EP0649310B1 (en) 2001-02-07
ATE199058T1 (en) 2001-02-15
AU661862B2 (en) 1995-08-10
EP0649310A1 (en) 1995-04-26
JP2523085B2 (en) 1996-08-07
CA2113360C (en) 1998-05-26
ES2155824T3 (en) 2001-06-01
DE69231686T2 (en) 2001-08-30
CA2113360A1 (en) 1993-02-04
BR9206266A (en) 1995-04-25
DE69231686D1 (en) 2001-03-15
DK0649310T3 (en) 2001-06-18
US5508046A (en) 1996-04-16
JPH06508636A (en) 1994-09-29
AU2410092A (en) 1993-02-23
EP0649310A4 (en) 1994-04-06
GR3035654T3 (en) 2001-06-29
RU2127607C1 (en) 1999-03-20

Similar Documents

Publication Publication Date Title
US5508046A (en) Stable, anticorrosive peracetic/peroxide sterilant
US5840343A (en) Room temperature sterilant for medical devices
US5616616A (en) Room Temperature sterilant
US5589507A (en) Method for sterilizing medical devices utilizing a room temperature sterilant
KR100317577B1 (en) Composition and uses thereof
EP0662783B1 (en) Antimicrobial composition and method of preparation
CN104206413B (en) A kind of thimerosal for haemodialysis control unit cleaning and sterilizing and preparation method thereof
CN100384753C (en) Sterilization method of ultrapure transmission system for microelectronic equipment
CN110024809A (en) The disinfectant concentrate of stable storing and its application
Coates et al. Sporicidal activity of mixtures of alcohol and hypochlorite.
US6331514B1 (en) Sterilizing and disinfecting compound
KR100363896B1 (en) A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution
KR102353182B1 (en) Percitric acid aqueous solution and method for producing the same
EP0184297A1 (en) Buffered glutaraldehyde sterilizing and disinfecting compositions
CN113749094B (en) Peracetic acid disinfectant for endoscope and preparation method thereof
KR102353181B1 (en) Peracetic acid aqueous solution and method for producing the same
WO2001034754A1 (en) Sterilizing and disinfecting compound
HU214960B (en) Stable, anticorrosive peracetic/peroxide sterilant and method for its preparation
Cheeseworth et al. A Contribution to our Knowledge of Disinfectant Action. III. Unsaturated Compounds as Germicides
Mosley Factors affecting the germicidal activity of iodophor germicides
EP3847890A1 (en) Disinfectant for legionella bacteria, water treatment method, bathwater additive, and additive for air-conditioning cooling tower water
JPH0780470A (en) Water treatment agent for strerilization
JPH0780468A (en) Water treatment agent for sterilization

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 08162065

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1992916914

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2113360

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1992916914

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992916914

Country of ref document: EP